$CE

Celanese Corp

2
2
0

No SEC Form 4 filings for $CE in the last 30 days.

Med

JPMorgan adds this 'unloved' value stock to its favorite buys list

JPMorgan analyst Jeffery Zekauskas added Celanese to its favorite buys list, keeping an overweight rating and raising its price target to $76 from $68, citing expected 2026 earnings gains from Acetyl Chain price inflation and improving Engineered Materials volumes. Celanese shares are down about 10% in 2026 after a Q2 beat, with leverage concerns. LSEG shows 10 of 18 analysts rated buy/strong buy.

Celanese Corp (CE): Results of Operations and Financial Condition

Celanese Corp (CE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 q220268-kex992.htm EX-99.2 Document Exhibit 99.2 Non-U.S. GAAP Financial Measures and Supplemental Information August 4, 2026 In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis. Purpose Th

Business Watch: War doesn’t stop Gulf chemical makers; BMS and AstraZeneca reportedly in merger talks

Business Watch reports Middle East petrochemical firms Sabic and Borouge posted strong Q2 results despite the Strait of Hormuz disruption, citing rerouted shipments and facility repairs. It also notes a Dutch court rejected Shell’s about $1 billion ethylene-damages claim. Lenzing plans to shutter Austrian and UK lyocell plants, and GAIL will expand gas-based fertilizer output with RCF.

CE sentiment & insider activity

Over the past 7 days, alphai's AI scored 4 news stories mentioning CE (Celanese Corp). Coverage has skewed bullish: 2 bullish, 2 neutral, and 0 bearish.

Recent CE coverage spans financial news, earnings and corporate actions.

What's driving CE

  • The incremental decision is a fresh analyst target increase tied to 2026 earnings drivers in Acetyl Chain and improving Engineered Materials volumes.

    cnbc.com · Aug 6, 2026

  • This filing is primarily accounting and supplemental-measure disclosure, not a new earnings print or guidance change in the provided text.

    SEC EDGAR 8-K · Aug 4, 2026

  • Court dismissal weakens the alleged-liability narrative for Celanese in this specific ethylene damages case.

    acs.org · Aug 4, 2026

  • The credit agreement amendment can change borrowing costs and covenant flexibility based on debt ratings and leverage tests, affecting near-term financing risk and optionality.

    SEC EDGAR 8-K · Aug 4, 2026

  • Court dismissal reduces Celanese’s litigation exposure tied to the 2020 European Commission settlement over past ethylene purchases.

    finanznachrichten.de · Jul 30, 2026

alphai scores every news story that mentions CE with an AI model for sentiment and relevance, and aggregates insider trades from Celanese Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CE

Score
$CEMed

JPMorgan adds this 'unloved' value stock to its favorite buys list

JPMorgan analyst Jeffery Zekauskas added Celanese to its favorite buys list, keeping an overweight rating and raising its price target to $76 from $68, citing expected 2026 earnings gains from Acetyl Chain price inflation and improving Engineered Materials volumes. Celanese shares are down about 10% in 2026 after a Q2 beat, with leverage concerns. LSEG shows 10 of 18 analysts rated buy/strong buy.

$CELow

Celanese Corp (CE): Results of Operations and Financial Condition

Celanese Corp (CE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 q220268-kex992.htm EX-99.2 Document Exhibit 99.2 Non-U.S. GAAP Financial Measures and Supplemental Information August 4, 2026 In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis. Purpose Th

$LINMed

Business Watch: War doesn’t stop Gulf chemical makers; BMS and AstraZeneca reportedly in merger talks

Business Watch reports Middle East petrochemical firms Sabic and Borouge posted strong Q2 results despite the Strait of Hormuz disruption, citing rerouted shipments and facility repairs. It also notes a Dutch court rejected Shell’s about $1 billion ethylene-damages claim. Lenzing plans to shutter Austrian and UK lyocell plants, and GAIL will expand gas-based fertilizer output with RCF.

$CEMed

Celanese Corp (CE): Entry into a Material Definitive Agreement

Celanese Corp (CE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 tm2622089d1_ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 Execution Version FIRST AMENDMENT TO CREDIT AGREEMENT FIRST AMENDMENT TO CREDIT AGREEMENT, dated as of July 31, 2026 (this “ First Amendment ”), by and among Celanese Corporation, a Delaware corporation (“ Holdings ”), Ce

Celanese Corporation: Amsterdam District Court Rules in Favor of Celanese and its Co-Defendants in Shell and Repsol Cases, Dismissing All Claims

Celanese (NYSE: CE) said the Amsterdam District Court dismissed Shell Chemicals Europe’s damages claim and a Repsol entities claim seeking declaratory judgment of liability against Celanese and co-defendants. The cases stem from follow-on litigation related to a 2020 European Commission settlement over past ethylene purchases in North-Western Europe.

$CELow

Celsius Shares Reclaim 20-Day and 50-Day Moving Averages as Momentum Shifts - Celsius Holdings (NASDAQ:CE

Celsius Holdings (NASDAQ:CE) shares rebounded as price reclaimed the 20- and 50-day moving averages. The stock is about 9.3% above its 20-day SMA ($29.13) and 3.8% above its 50-day SMA ($30.65), but still ~12% below the 100-day SMA ($36.18) and ~27.3% below the 200-day SMA ($43.77). UBS maintained a Buy rating but cut its target to $50 from $55. Shares were up 4.36% to $33.26.

Tag: Celanese Corp.

The market for cellulose acetate (CA) tow, used in cigarette filters, has tightened significantly due to various factors. Celanese Corp. declared force majeure in May 2022, and other manufacturers like Cerdia announced price hikes. Increased raw material costs, supply chain disruptions exacerbated by the Covid-19 pandemic and the Russia-Ukraine conflict, and rising demand from heated-tobacco products (HTPs) are contributing to the supply scarcity and higher prices.

$CEMed

Celanese (NYSE:CE) Price Target Raised to $81.00 at Citigroup

Citigroup has increased its price target for Celanese (NYSE:CE) from $75.00 to $81.00, maintaining a "buy" rating and suggesting a potential upside of 34.71%. This comes despite Celanese missing its recent quarterly earnings and revenue estimates. While analyst coverage remains mixed, other firms have also adjusted their price targets and ratings, with some recent upgrades along with earlier downgrades in response to earnings and market conditions.

Related tickers